Last reviewed · How we verify

NCT05145530

Selective Nerve Root Block With Ultrasound Guidance Improves Surgical Outcome of Selective Discectomy in Patients With Multilevel Cervical Disc Disease

Completed Phase 2, PHASE3 Last updated 4 January 2022
What this trial tests

Phase 2, PHASE3 trial testing selective anterior cervical discectomy and fusion (ACDF) in Selective Nerve Root Block in 60 participants. Completed in 30 April 2020.

Timeline
10 August 2017
Primary endpoint
30 March 2020
30 April 2020

Quick facts

Lead sponsorAssiut University
PhasePhase 2, PHASE3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment60
Start date10 August 2017
Primary completion30 March 2020
Estimated completion30 April 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 30 to 60, any sex, with Selective Nerve Root Block or Selective Discectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Disc degeneration is a natural part of growing older. Up to 60% of asymptomatic people have MRI findings that are positive. As a result, MRI only provides morphological information and may not be able to determine the clinical significance of the findings.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Ultrasound-Guided Selective Nerve Root Block for Surgical Planning in Multilevel Cervical Disc Disease: A Technical Report.
    Lam KHS, Yoon Y, Su DC, Suhaimi A, et al · · 2026 · PMID 42028518 · DOI 10.7759/cureus.105690

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05145530.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing